Collegium Pharmaceutical (COLL) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free COLL Stock Alerts $33.14 +0.71 (+2.19%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical Short Interest DataCurrent Short Interest6,930,000 sharesPrevious Short Interest6,860,000 sharesChange Vs. Previous Month+1.02%Dollar Volume Sold Short$235.48 millionShort Interest Ratio14.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares32,720,000 sharesFloat Size31,980,000 sharesShort Percent of Float21.67%Today's Trading Volume566,503 sharesAverage Trading Volume528,867 sharesToday's Volume Vs. Average107% Short Selling Collegium Pharmaceutical ? Sign up to receive the latest short interest report for Collegium Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCOLL Short Interest Over TimeCOLL Days to Cover Over TimeCOLL Percentage of Float Shorted Over Time Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. Collegium Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,930,000 shares $235.48 million +1.0%21.7%14.7 $33.98 4/30/20246,860,000 shares $253.34 million -1.9%21.8%16.4 $36.93 4/15/20246,990,000 shares $245.63 million -1.8%22.9%17.3 $35.14 3/31/20247,120,000 shares $276.40 million +1.6%23.3%17.5 $38.82 3/15/20247,010,000 shares $274.02 million +4.3%22.9%15.7 $39.09 2/29/20246,720,000 shares $246.69 million -1.5%22.0%15.4 $36.71 Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,820,000 shares $231.54 million +0.9%22.3%16.1 $33.95 1/31/20246,760,000 shares $222.81 million +6.5%21.4%16.3 $32.96 1/15/20246,350,000 shares $206.44 million -0.5%20.1%15.2 $32.51 12/31/20236,380,000 shares $196.38 million -3.6%20.2%15.9 $30.78 12/15/20236,620,000 shares $196.22 million +0.3%20.9%18.5 $29.64 11/30/20236,600,000 shares $169.16 million -2.9%20.8%21.7 $25.63 11/15/20236,800,000 shares $169.73 million +13.1%21.5%22.9 $24.96 10/31/20236,010,000 shares $130.78 million -7.3%17.8%22.3 $21.76 10/15/20236,480,000 shares $141.91 million +0.2%19.2%21.2 $21.90 9/30/20236,470,000 shares $144.60 million -6.5%19.2%21.8 $22.35 9/15/20236,920,000 shares $156.74 million -6.5%20.5%23.6 $22.65 8/31/20237,400,000 shares $173.31 million -3.1%21.9%23.7 $23.42 8/15/20237,640,000 shares $181.83 million +28.6%22.6%24.6 $23.80 7/31/20235,940,000 shares $135.19 million -9.6%17.6%18.7 $22.76 7/15/20236,570,000 shares $141.98 million -1.5%19.5%21.2 $21.61 6/30/20236,670,000 shares $143.34 million +2.0%19.8%20.2 $21.49 6/15/20236,540,000 shares $144.73 million +4.1%19.4%19.4 $22.13 5/31/20236,280,000 shares $138.60 million -1.3%18.6%19.3 $22.07 5/15/20236,360,000 shares $149.46 million +2.1%19.2%17.7 $23.50 4/30/20236,230,000 shares $144.97 million +0.7%18.7%13.5 $23.27 4/15/20236,190,000 shares $141.94 million +6.2%18.9%13.9 $22.93 3/31/20235,830,000 shares $139.86 million +2.3%17.8%12.6 $23.99 3/15/20235,700,000 shares $134.81 million +4.2%17.4%11.9 $23.65 2/28/20235,470,000 shares $145.12 million +16.1%16.8%11.7 $26.53 2/15/20234,710,000 shares $128.44 million +19.5%14.5%10.8 $27.27 1/31/20233,940,000 shares $110.64 million -0.8%12.2%9.4 $28.08 1/15/20233,970,000 shares $114.06 million +8.5%12.3%13 $28.73 12/30/20223,660,000 shares $84.91 million +2.0%11.3%13 $23.20 12/15/20223,590,000 shares $80.74 million -4.5%11.1%15.8 $22.49 11/30/20223,760,000 shares $82.23 million -4.3%11.6%16.5 $21.87 11/15/20223,930,000 shares $84.61 million +2.3%12.2%17.1 $21.53 10/31/20223,840,000 shares $68.89 million -1.5%11.9%17.3 $17.94 10/15/20223,900,000 shares $69.77 million +2.6%11.9%17.7 $17.89 9/30/20223,800,000 shares $60.88 million +3.0%11.6%16.5 $16.02How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 9/15/20223,690,000 shares $66.75 million +1.9%11.3%14.4 $18.09 8/31/20223,620,000 shares $63.64 million -1.9%11.1%13.8 $17.58 8/15/20223,690,000 shares $69.34 million +3.4%11.3%13.3 $18.79 7/31/20223,570,000 shares $61.37 million +1.4%11.0%11.3 $17.19 7/15/20223,520,000 shares $58.19 million -2.5%10.8%10.5 $16.53 6/30/20223,610,000 shares $63.97 million -2.7%11.1%10.1 $17.72 6/15/20223,710,000 shares $59.81 million +7.2%11.4%9.9 $16.12 5/31/20223,460,000 shares $54.05 million +4.2%10.6%9.7 $15.62 5/15/20223,320,000 shares $51.92 million No Change10.2%8.2 $15.64 4/30/20223,320,000 shares $53.45 million -0.9%10.2%7.6 $16.10 4/15/20223,350,000 shares $64.25 million -2.1%10.3%8.1 $19.18 3/31/20223,420,000 shares $69.63 million -0.3%10.6%9 $20.36 3/15/20223,430,000 shares $62.22 million -5.3%10.7%10.1 $18.14 2/28/20223,620,000 shares $70.48 million +4.6%11.3%10.4 $19.47 2/15/20223,460,000 shares $75.50 million +4.5%10.4%10.6 $21.82 1/31/20223,310,000 shares $59.08 million -2.4%9.9%13 $17.85 1/15/20223,390,000 shares $62.85 million -2.0%10.1%11.8 $18.54 12/31/20213,460,000 shares $64.63 million -5.7%10.3%12.3 $18.68 12/15/20213,670,000 shares $68.45 million -15.4%11.0%12.6 $18.65 11/30/20214,340,000 shares $76.30 million -9.6%12.9%15.7 $17.58 11/15/20214,800,000 shares $96.05 million +24.7%14.3%17.8 $20.01 10/29/20213,850,000 shares $75.58 million +2.7%11.5%13 $19.63 10/15/20213,750,000 shares $78.68 million +1.1%10.9%13.2 $20.98 9/30/20213,710,000 shares $73.24 million +2.5%10.8%12.5 $19.74 9/15/20213,620,000 shares $71.89 million +6.8%10.5%12 $19.86 8/31/20213,390,000 shares $69.60 million -6.4%9.8%11.4 $20.53 8/13/20213,620,000 shares $64.26 million -12.1%10.5%11.9 $17.75 7/30/20214,120,000 shares $102.55 million -3.3%12.0%15 $24.89 7/15/20214,260,000 shares $100.20 million +1.7%12.5%17.2 $23.52 6/30/20214,190,000 shares $99.05 million -3.2%12.2%17.7 $23.64 6/15/20214,330,000 shares $99.37 million +7.2%12.6%17.3 $22.95 5/28/20214,040,000 shares $96.52 million -3.1%11.8%15.6 $23.89 5/14/20214,170,000 shares $90.66 million -3.9%N/A13.7 $21.74 4/30/20214,340,000 shares $96.57 million +0.7%N/A8.2 $22.25 4/15/20214,310,000 shares $103.53 million +1.4%N/A7.8 $24.02 3/31/20214,250,000 shares $101.32 million No Change13.0%7.3 $23.84 3/15/20214,250,000 shares $108.12 million -6.2%13.0%7.1 $25.44 2/26/20214,530,000 shares $117.92 million +8.9%13.9%7.8 $26.03 2/12/20214,160,000 shares $104.50 million -2.1%12.8%7.7 $25.12 1/29/20214,250,000 shares $104.55 million +2.7%13.1%11.7 $24.60 1/15/20214,140,000 shares $92.28 million +6.4%12.8%13.4 $22.29 12/31/20203,890,000 shares $77.49 million -0.8%11.9%13.9 $19.92 12/15/20203,920,000 shares $73.15 million -3.0%12.0%14.9 $18.66 11/30/20204,040,000 shares $77.53 million -14.8%12.3%15 $19.19 11/15/20204,740,000 shares $90.91 million +11.8%14.5%15.7 $19.18 10/30/20204,240,000 shares $76.49 million -4.5%12.9%14.1 $18.04 10/15/20204,440,000 shares $94.13 million +1.4%13.6%13.2 $21.20 9/30/20204,380,000 shares $91.19 million +3.8%13.4%12.5 $20.82 9/15/20204,220,000 shares $80.26 million +2.9%12.9%11.8 $19.02 8/31/20204,100,000 shares $78.15 million +3.3%12.5%10.7 $19.06How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 8/14/20203,970,000 shares $72.10 million -5.0%12.1%9.7 $18.16 7/31/20204,180,000 shares $65.96 million -3.9%13.0%9.4 $15.78 7/15/20204,350,000 shares $75.52 million -7.1%13.6%10.4 $17.36 6/30/20204,680,000 shares $80.22 million -6.8%14.7%10.3 $17.14 6/15/20205,020,000 shares $88.35 million +13.3%15.8%11 $17.60 5/29/20204,430,000 shares $97.68 million -3.5%13.9%8.7 $22.05 5/15/20204,590,000 shares $101.12 million -6.9%14.3%8.4 $22.03 4/30/20204,930,000 shares $101.66 million +2.9%15.7%6.6 $20.62 4/15/20204,790,000 shares $93.55 million +3.0%15.2%6.6 $19.53 3/31/20204,650,000 shares $95.60 million -16.7%15.0%6.5 $20.56 3/13/20205,582,500 shares $107.74 million +8.4%18.2%8.3 $19.30 2/28/20205,150,000 shares $71.59 million +17.3%16.8%8.1 $13.90 2/14/20204,390,000 shares $87.14 million +82.2%14.5%7.5 $19.85 1/31/20202,410,000 shares $54.39 million +4.3%8.3%4.7 $22.57 1/15/20202,310,000 shares $51.31 million +13.2%7.9%5.1 $22.21 12/31/20192,040,000 shares $42.74 million +22.9%7.0%4.6 $20.95 COLL Short Interest - Frequently Asked Questions What is Collegium Pharmaceutical's current short interest? Short interest is the volume of Collegium Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 6,930,000 shares of COLL short. 21.67% of Collegium Pharmaceutical's shares are currently sold short. Learn More on Collegium Pharmaceutical's current short interest. What is a good short interest ratio for Collegium Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COLL shares currently have a short interest ratio of 15.0. Learn More on Collegium Pharmaceutical's short interest ratio. Which institutional investors are shorting Collegium Pharmaceutical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Collegium Pharmaceutical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Collegium Pharmaceutical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.67% of Collegium Pharmaceutical's floating shares are currently sold short. Is Collegium Pharmaceutical's short interest increasing or decreasing? Collegium Pharmaceutical saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,930,000 shares, an increase of 1.0% from the previous total of 6,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Collegium Pharmaceutical's float size? Collegium Pharmaceutical currently has issued a total of 32,720,000 shares. Some of Collegium Pharmaceutical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Collegium Pharmaceutical currently has a public float of 31,980,000 shares. How does Collegium Pharmaceutical's short interest compare to its competitors? 21.67% of Collegium Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Collegium Pharmaceutical: Nektar Therapeutics (1.49%), Inozyme Pharma, Inc. (6.46%), Eagle Pharmaceuticals, Inc. (9.97%), Alpine Immune Sciences, Inc. (5.67%), Nuvalent, Inc. (20.34%), Alkermes plc (7.65%), Perrigo Company plc (3.08%), Crinetics Pharmaceuticals, Inc. (6.23%), Axsome Therapeutics, Inc. (15.98%), Biohaven Ltd. (10.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Collegium Pharmaceutical stock? Short selling COLL is an investing strategy that aims to generate trading profit from Collegium Pharmaceutical as its price is falling. COLL shares are trading up $0.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Collegium Pharmaceutical? A short squeeze for Collegium Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COLL, which in turn drives the price of the stock up even further. How often is Collegium Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COLL, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NKTR Short Interest INZY Short Interest EGRX Short Interest ALPN Short Interest NUVL Short Interest ALKS Short Interest PRGO Short Interest CRNX Short Interest AXSM Short Interest BHVN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COLL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.